Santhera Pharmaceuticals Holding AG (SWX:SANN)

SWX:SANN Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 4, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	180	90	75	56	54	126
Market Cap Growth	-1.83%	19.92%	34.92%	3.51%	-57.20%	76.29%
Enterprise Value	190	130	103	91	96	177
Last Close Price	14.32	9.81	13.80	13.30	28.00	113.40
PE Ratio	2.51	1.65	-	-	-	-
PS Ratio	1.34	0.87	10.08	-35.00	3.59	1.67
PB Ratio	3.49	1.51	-1.72	42.04	-8.49	5.93
P/FCF Ratio	3.82	1.91	-	-	-	50.46
P/OCF Ratio	1.99	1.91	-	-	-	48.56
EV/Sales Ratio	1.67	1.26	13.82	-	6.41	2.35
EV/EBITDA Ratio	3.30	2.42	-	-	-	-
EV/EBIT Ratio	3.54	2.54	-	-	-	-
EV/FCF Ratio	4.03	2.76	-	-	-	71.03
Debt / Equity Ratio	0.55	0.36	-1.02	32.36	-11.20	2.82
Debt / EBITDA Ratio	0.46	0.40	-	-	-	-
Debt / FCF Ratio	0.56	0.46	-	-	-	24.03
Asset Turnover	1.33	1.19	0.10	-	0.15	0.67
Inventory Turnover	-	3.37	13.40	8.29	2.84	0.68
Quick Ratio	0.51	0.73	0.05	0.71	0.58	1.68
Current Ratio	0.63	0.78	0.06	0.75	0.61	2.06
Return on Equity (ROE)	2374.13%	673.95%	-	-	-908.60%	-77.32%
Return on Assets (ROA)	39.20%	36.89%	-36.95%	-39.55%	-32.56%	-5.79%
Return on Capital (ROIC)	91.78%	77.76%	-126.97%	-65.17%	-45.42%	-7.98%
Return on Capital Employed (ROCE)	97.30%	78.30%	-	-	-	-
Earnings Yield	34.85%	60.65%	-94.37%	-99.47%	-125.46%	-15.06%
FCF Yield	26.16%	52.24%	-39.69%	-66.92%	-80.73%	1.98%
Buyback Yield / Dilution	-24.61%	-79.29%	-78.31%	-156.61%	-21.15%	-59.49%

Updated Sep 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.